Andrew H Ko (Andrew Ko)

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 9

Top Topics

Locally Advanced

Prognostic Factors

Neoadjuvant Chemotherapy

Top Venues

Cancer research communications

Investigational new drugs

This page only lists publications with an associated author ORCID identifier.

Publications

Kathleen Elizabeth Rodgers, Erin L Filbert, Hai Yang, Stephanie Starzinski, Alec Starzinski, Marissa Gin, Brandon K Chen, Phi Le, Tony Li, Brandon Bol, Alexander Cheung, Li Zhang, Frank J Hsu, Andrew H Ko, Lawrence Fong, Bridget P Keenan
Neoadjuvant CD40 agonism remodels the tumor immune microenvironment in locally advanced esophageal/gastroesophageal junction cancer. Cancer research communications (2024)
Kathleen Elizabeth Rodgers, Erin L Filbert, Hai Yang, Stephanie Starzinski, Alec Starzinski, Marissa Gin, Brandon K Chen, Phi Le, Tony Li, Brandon Bol, Alexander Cheung, Li Zhang, Frank J Hsu, Andrew H Ko, Lawrence Fong, Bridget P Keenan
Neoadjuvant CD40 Agonism Remodels the Tumor Immune Microenvironment in Locally Advanced Esophageal/Gastroesophageal Junction Cancer. Cancer research communications 4 (1) (2024)
Kathleen Elizabeth Rodgers, Erin L Filbert, Hai Yang, Stephanie Starzinski, Alec Starzinski, Marissa Gin, Brandon K Chen, Phi Le, Tony Li, Brandon Bol, Alexander Cheung, Li Zhang, Frank J Hsu, Andrew H Ko, Lawrence Fong, Bridget P Keenan
Neoadjuvant CD40 Agonism Remodels the Tumor Immune Microenvironment in Locally Advanced Esophageal/Gastroesophageal Junction Cancer. Cancer research communications 4 (1) (2024)
Andrew H Ko, Andrew L Coveler, Benjamin L Schlechter, Tanios Bekaii-Saab, Brian M Wolpin, Jeffrey W Clark, Bruno Bockorny, Li-Yuan Bai, Yu-Chin Lin, Evelyn Chiang, Peter Langecker, Shih-Yao Lin
A multicenter phase Ia study of AbGn-107, a novel antibody-drug conjugate, in patients with advanced gastrointestinal cancer. Investigational new drugs 42 (2) (2024)
Kathleen Elizabeth Rodgers, Erin L Filbert, Hai Yang, Stephanie Starzinski, Alec Starzinski, Marissa Gin, Brandon K Chen, Phi Le, Tony Li, Brandon Bol, Alexander Cheung, Li Zhang, Frank J Hsu, Andrew H Ko, Lawrence Fong, Bridget P Keenan
Neoadjuvant CD40 agonism remodels the tumor immune microenvironment in locally advanced esophageal/gastroesophageal junction cancer. Cancer research communications (2024)
Andrew H Ko, Andrew L Coveler, Benjamin L Schlechter, Tanios Bekaii-Saab, Brian M Wolpin, Jeffrey W Clark, Bruno Bockorny, Li-Yuan Bai, Yu-Chin Lin, Evelyn Chiang, Peter Langecker, Shih-Yao Lin
A multicenter phase Ia study of AbGn-107, a novel antibody-drug conjugate, in patients with advanced gastrointestinal cancer. Investigational new drugs 42 (2) (2024)
Kathleen Elizabeth Rodgers, Erin L Filbert, Hai Yang, Stephanie Starzinski, Alec Starzinski, Marissa Gin, Brandon K Chen, Phi Le, Tony Li, Brandon Bol, Alexander Cheung, Li Zhang, Frank J Hsu, Andrew H Ko, Lawrence Fong, Bridget P Keenan
Neoadjuvant CD40 Agonism Remodels the Tumor Immune Microenvironment in Locally Advanced Esophageal/Gastroesophageal Junction Cancer. Cancer research communications 4 (1) (2024)
Andrew H Ko, Andrew L Coveler, Benjamin L Schlechter, Tanios Bekaii-Saab, Brian M Wolpin, Jeffrey W Clark, Bruno Bockorny, Li-Yuan Bai, Yu-Chin Lin, Evelyn Chiang, Peter Langecker, Shih-Yao Lin
A multicenter phase Ia study of AbGn-107, a novel antibody-drug conjugate, in patients with advanced gastrointestinal cancer. Investigational new drugs (2024)
Kathleen Elizabeth Rodgers, Erin L Filbert, Hai Yang, Stephanie Starzinski, Alec Starzinski, Marissa Gin, Brandon K Chen, Phi Le, Tony Li, Brandon Bol, Alexander Cheung, Li Zhang, Frank J Hsu, Andrew H Ko, Lawrence Fong, Bridget P Keenan
Neoadjuvant CD40 agonism remodels the tumor immune microenvironment in locally advanced esophageal/gastroesophageal junction cancer. Cancer research communications (2024)